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A systems biology approach to 
defining regulatory mechanisms 
for cartilage and tendon cell 
phenotypes
A. J. Mueller1, S. R. Tew1,2, O. Vasieva3, P. D. Clegg1,2 & E. G. Canty-Laird1,2
Phenotypic plasticity of adult somatic cells has provided emerging avenues for the development 
of regenerative therapeutics. In musculoskeletal biology the mechanistic regulatory networks of 
genes governing the phenotypic plasticity of cartilage and tendon cells has not been considered 
systematically. Additionally, a lack of strategies to effectively reproduce in vitro functional models of 
cartilage and tendon is retarding progress in this field. De- and redifferentiation represent phenotypic 
transitions that may contribute to loss of function in ageing musculoskeletal tissues. Applying a 
systems biology network analysis approach to global gene expression profiles derived from common 
in vitro culture systems (monolayer and three-dimensional cultures) this study demonstrates common 
regulatory mechanisms governing de- and redifferentiation transitions in cartilage and tendon cells. 
Furthermore, evidence of convergence of gene expression profiles during monolayer expansion 
of cartilage and tendon cells, and the expression of key developmental markers, challenges the 
physiological relevance of this culture system. The study also suggests that oxidative stress and PI3K 
signalling pathways are key modulators of in vitro phenotypes for cells of musculoskeletal origin.
The musculoskeletal system consists of a diverse group of tissues that facilitate movement and are developmen-
tally, anatomically, and functionally interrelated. Of the musculoskeletal tissues, cartilage and tendon progeni-
tor cells arise from common mesenchymal precursors with variable expression of Sox9 (SRY (Sex Determining 
Region Y)-Box 9), and scleraxis (Scx), a basic helix-loop-helix (bHLH) transcription factor1,2. Furthermore, both 
tissues are comprised of highly specialized extracellular matrices with distinct architecture, are relatively acellular, 
avascular, and aneural with quiescent resident cell populations in physiological states. Both tissues show insidious 
degeneration with age and represent highly prevalent co-morbidities within ageing populations3.
In general, within the field of musculoskeletal biology, there has been little attention given to comparative 
studies of the constituent tissues of this system. The highly specialized three-dimensional structures inherent to 
the function of cartilage and tendon have yet to be adequately modelled in vitro4,5. Consequently, extrapolation 
of findings and translation to therapies is limited for these tissues. The dearth of disease modulating therapeutics 
may, in part, be associated with a deficiency of available in vitro models.
Resident tissue progenitor cells are reported to be isolated from both cartilage6 and tendon7. Additionally, 
methods to manipulate the phenotype of adult somatic cells8 have shown that the differentiated state is reversible 
and degrees of phenotypic plasticity exist. Terms including de-, re-, and trans-differentiation represent alterations 
in the synthetic profile of adult somatic cells that may be relevant to tissue regeneration9. Dedifferentiation, a 
loss of cellular functionality, is a term with no definitive mechanism, yet is used to describe distinct and diverse 
biological contexts10,11, including the response to monolayer expansion of chondrocytes12 and tenocytes13. 
Recent evidence also implicates the loss of differentiated (functional) status as a factor in degenerative disease 
with the inference that dedifferentiation of chondrocytes has some comparison with osteoarthritis pathways14. 
Consequently, exploration of mechanisms that may contribute to a deeper understanding of degenerative and 
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regenerative phenotypes could help elucidate points for therapeutic intervention in conditions such as osteoar-
thritis and tendinopathy.
Biological phenomena, such as development, are complex dynamic processes. They cannot be reduced to the 
characteristics of their components and need to be described by interactions within multiple hierarchical levels 
comprising a system. Systems bioinformatics approaches, such as gene co-expression network reconstruction15 
and pathway analysis16, facilitate a high-level understanding of a system under investigation.
A major obstacle to the development of in vitro cartilage models and therapeutic interventions is the capacity 
to control differentiation5. The plethora of biomolecules known to modulate the chondrocyte phenotype14 and 
the dynamic and transient nature of regulator expression, e.g. TGF-β 1 oscillations17, suggest that manipulating 
differentiation through the application of a small number of growth factors with an invariant temporal pro-
file is unlikely to be successful5. Systems biology approaches are well-suited to tackling the complexity of such 
relationships.
This study revisits the dedifferentiation/redifferentiation paradigm in chondrocytes using a sytems biology 
based approach and compares these processes with those occurring in tenocytes subjected to similar conditions. 
Using transcriptomic profiling and systems biology techniques the objective was to provide a clear hypothetical 
mechanistic description of the impact that in vitro environmental perturbations have on the system and evaluate 
the adequacy of three-dimensional in vitro culture models as proxies for cartilage and tendon. We hypothesised 
that the regulatory mechanisms that governed phenotypes in cartilage and tendon cells would be comparable 
in standard three-dimensional culture models. By establishing standardised characteristics for in vitro models, 
proposing regulatory mechanisms, and defining core differences between the cell types, step-wise improvements 
in the differentiated status of in vitro models may be achieved through further investigations.
Results
Dedifferentiated cells show convergence of gene expression profiles. Using the top 500 genes 
showing the greatest covariance in expression (Supplementary Data, SD1) 36 samples could be clustered into four 
distinct groups by principal component analysis (PCA), Fig. 1a. The first two principal components described 
70.2% of the variation in the data. These groups consisted of: (i) native cartilage; (ii) native tendon; (iii) all mon-
olayer cultured chondrocytes, tenocytes, and fibroblasts; (iv) or three-dimensional culture systems (alginate or 
fibrin cultures). Overall, few genes were differentially expressed between cell types in monolayer at passage five 
or between three-dimensional culture conditions, Fig. 1b. The variation in the gene expression was suggestive of 
a convergence of expression profiles for cells in monolayer and a failure of chondrocytes or tenocytes in three-di-
mensional culture to recapitulate differentiation status to parity with native tissue.
Gene ontology descriptions. Dedifferentiated (monolayer) chondrocytes and tenocytes demonstrated 
frequent overlap in enriched biological process annotations. Complete annotations are available (Supplementary 
Data, SD2–SD7) with summary terms provided in Table 1. Shared functional terms for dedifferentiation were 
associated with: metabolism, development, extracellular matrix organisation, and redox balance. Response to 
oxidative stress, apoptosis, and metabolic process terms were significantly associated with genes more highly 
expressed in chondrocytes and tenocytes in three-dimensional cultures. Developmental terms relating to ‘vascu-
lature development’, ‘cardiovascular development’, ‘post-embryonic development’ and ‘regulation of anatomical 
structure morphogenesis’ were defined for chondrocytes in alginate bead cultures and ‘collagen catabolic process’ 
for tenocytes in fibrin constructs.
Native tissues exhibit complex and distinct transcriptomic profiles. Cartilage. Relative to 
monolayer-expanded chondrocytes, cartilage in adult rats was characterised by higher expression of colla-
gen type II (Col2a1), aggrecan (Acan), thrombospondin 4 (Thbs4), chondroadherin (Chad), alkaline phos-
phatase (Alpl), clusterin (Clu), dentin matrix acidic phosphoprotein (Dmp1), and integrin-binding sialoprotein 
(Ibsp). Additionally, CCN-family genes, proteoglycans, cathepsins, chemokines, homeodomain genes, innate 
immune-associated elements and cytoskeletal-associated kinesins and tubulins were strongly represented in car-
tilage relative to monolayer chondrocytes, Table 2. Comprehensive tables of differentially expressed genes for all 
conditions are found in Supplementary Data (SD8–SD17).
Tendon. Troponins and myosins were the most highly expressed gene group in native tendon; specifically tro-
ponin I type 2 (Tnni2), actin α 1 (Acta1) and creatine kinase (Ckm) had higher expression in native tendon relative 
to monolayer. Tenomodulin (Tnmd), mustang (Mustn1), elastin (Eln), keratocan (Kera), lubricin (Prg4), der-
matopontin (Dpt), and apolipoprotein (ApoE) were more highly expressed in native tendon than in monolayer. 
Relative to native cartilage, tendon exhibited higher expression of Serpinf1, Myod1, Igfbp6, Thbs4, and clusterin 
(Clu). There were fewer differentially expressed genes between tendon and 3D cultures than cartilage and 3D 
cultures indicating a difference in the complexity of the synthetic profiles between the two tissues, Fig. 1b.
Dedifferentiated cells express developmental markers. The fewest statistically significant genes were 
found between monolayer chondrocytes and tenocytes (Fig. 1b) with a number of genes highly expressed by both 
in monolayer. At passage five monolayer cells demonstrated higher expression of mesenchymal markers Thy1 
(also known as CD90) and prion protein encoding gene, Prnp, epithelial-mesenchymal transition regulator Snai1, 
and bHLH transcription factor Twist1. The TGF-β signalling elements Tgfb2, Tgfb3, Smad6 and inhibitor Smad7, 
were also more highly expressed in monolayer culture, Table 2. Development-associated homeobox genes, encod-
ing homeodomain proteins, expressed more highly in monolayer chondrocytes included Pitx1, a hind-limb cod-
ing gene, and Prrx2, a differentiation-associated homeobox gene. Wnt-signalling frizzled family receptors Fzd1, 
Fzd2 and Fzd8 were more highly expressed in monolayer chondrocytes than cartilage, except Wnt-signalling 
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Figure 1. (a) Principal component analysis of gene expression data from 36 Illumina arrays profiling three cell 
types (cell type) and isolated from three environmental conditions (condition) – native (cartilage or tendon 
tissue), monolayer (passage 5, dedifferentiated), or 3D (alginate or fibrin cultures). The figure demononstrates 
the clustering of samples using the first two principal components (PC1, PC2), which together explain > 70% of 
the variation in the data for the top 500 most covariant genes, Supplementary Data, SD1. Covariance is used to 
measure how random genes change with respect to one another. The figure demonstrates that the genes showing 
the greatest covariance explain the majority of the differences observed between the experimental groups. Cells 
in monolayer, derived from cartilage, tendon, or dermal fibroblasts, group when only the most covariant genes 
are considered. Chondrocytes and tenocytes in three-dimensional cultures also group together, but not with 
their tissues of origin. Overall, there were fewer genes differentially expressed between native tendon and 3D 
fibrin cultures than between native cartilage and 3D alginate cultures. This greater complexity in the synthetic 
profile of cartilage is indicated by the clustering of cartilage samples distant from all other samples. (b) Matrix of 
up- and down-regulated genes for selected pairwise comparisons involving different environmental conditions 
for chondrocytes and tenocytes. Values indicate the number of up- or down- regulated genes with a log2 fold 
change > + /− 0.5, FDR < 0.01 and a log-odds ratio of expression > 0 (~50%). Duplicate Entrez gene identifiers 
are removed. The fewest differentially expressed genes were found between cultured cells, for example only 
154 genes were more highly expressed in chondrocytes relative to monolayer tenocytes; 135 genes had lower 
expression in chondrocytes than tenocytes (289 differentially expressed in total). Number of genes showing 
higher expression (positive log2 fold-change, upward hatch) and lower expression (negative log2 fold-change, 
downward hatch) in each comparison are indicated.
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modulator Frzb, which demonstrated the reciprocal relationship. Dedifferentiated tenocytes expressed higher 
levels of genes associated with development, transcription factors, serine protease Serpine1, biglycan (Bgn), and 
the homolog of slit (Drosophila), Slit3.
Three-dimensional cultures do not restitute dedifferentiated cells. There were 283 genes found to 
be more highly expressed in three-dimensional culture systems relative to native tissue, i.e. common to alginate 
and fibrin cultures, Fig. 1b. In three-dimensional cultures Fos and Junb, the components of the AP-1 heterodi-
meric transcription factor, the transmembrane glycoprotein osteoactivin gene Gpnmb, clusterin (Clu) and the 
bone morphogenetic protein receptor, type 1a (Bmpr1a) were all more highly expressed. Consistent with the gene 
ontology annotations there was upregulation of genes associated with oxidative stress (Nfe2l2), hypoxia (Hif1a) 
and anti-oxidant responses (Sod2, Hmox1) in both 3D culture systems. The transcription factor Vegfb, chemok-
ine ligand 1 Cxcl1, and prostaglandin-endoperoxide synthase 2 (Ptgs2) were also more highly expressed in both 
culture systems.
Redifferentiating chondrocytes exhibited higher expression of immune-associated genes including cytokines, 
chemokines, and alarmin genes, as well as a number of chondrogenesis-associated genes, Table 2. Tenocytes 
in fibrin cultures, when compared to native tendon, expressed higher levels of metallothionein 1a (Mt1a), the 
BMP-antagonist and tendon development gene gremlin 1 (Grem1), and enolase 2 (Eno2), a neuron-associated 
enolase isoenzyme. The tenascin N/W isoform, Tnn, was highly expressed in fibrin cultures.
Validation of differentially expressed genes by qPCR. Genes chosen for corroboration of expression 
by qPCR were either common to culture systems, known or putative markers of developmental or differentiated 
musculoskeletal tissue. Genes with established differentiation roles in cartilage (Sox9) and tendon (Scx, Mkx) 
were also assessed although not found to be differentially expressed in microarray analysis.
Significant reductions in the expression of Col2a1, Acan, and Sox9 for dedifferentiated chondrocytes, Fig. 2, 
and Tnmd and Serpinf1 for dedifferentiated tenocytes, Fig. 3, were confirmed. The higher expression of Thbs4 in 
cartilage relative to monolayer chondrocytes was not confirmed by qPCR. Both dedifferentiated chondrocytes 
and tenocytes were shown to have elevated expression of scleraxis (Scx), prion (Prnp) and Thy1 and a reduction 
in Sox9 expression. Alginate and fibrin 3D cultures expressed significantly higher levels of Hif1a and Nfe2l2, 
relative to native tendon or cartilage. Fibrin cultures significantly elevated expression of Atf4; a comparable trend 
was observed in alginate cultures. Alginate cultures exhibited higher expression of Pitx1 and Sox9, whilst fibrin 
cultures up-regulated Thbs4, Scx, and Slit3. Expression of tissue-specific differentiation markers (Tnmd, Col2a1) 
was not restored in three-dimensional cultures.
Pathway topology analysis defines consensus canonical pathways. Signalling Pathway Impact 
Analysis (SPIA), which uses a combination of over-expression analysis of differentially expressed gene lists, 
Source|Cartilage Biological Process Source|Tendon Biological Process
Native
Immune system process
Native
Muscle system process
Immune response Muscle contraction
Cell cycle Immune system process
Defense response Skeletal muscle tissue development
Actin filament-based 
process
Monolayer
(chondrocytes)
Single-organism metabolic 
process
Monolayer
(tenocytes)
Cell-redox homeostasis
Extracellular matrix organisation Response to endoplasmic reticulum stress
Oxidation-reduction process Single organism metabolic process
Cardiovascular system 
development
Developmental process
Alginate
cultures
Single-organism metabolic 
process
Fibrin
cultures
Translation
Oxidation-reduction process Metabolic process
Lipid metabolic process Response to oxidative stress
Response to oxidative stress Apoptotic signalling pathway
Apoptotic signalling pathway Collagen catabolic process
Table 1.  Summary of gene ontology biological process annotations derived from genes most highly 
expressed in each condition. All functional terms are significantly enriched at FDR < 0.001 and filtered for 
redundant terms. Native cartilage and tendon were annotated with distinct functional terms, but overlapped 
for immune-associated biological processes. In contrast, monolayer chondrocytes and tenocytes demonstrated 
frequent overlap in functional annotations (see Supplementary Data, SD2–SD7). The terms ‘response to 
oxidative stress’ and ‘apoptotic signalling’ were common to fibrin and alginate cultures.
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magnitude of fold-change, and the topology of KEGG canonical signalling pathways to define global pathway 
perturbation scores, predicted activation of ‘focal adhesion’, ‘rheumatoid arthritis’ and ‘systemic lupus erythema-
tosus’ reference pathways in both native tissue to monolayer comparisons, Fig. 4. The HIF-1 and PI3K signalling 
pathways were predicted to be reciprocally inhibited or activated in de- and redifferentiation, respectively, for 
both cell types, see Supplementary Data (SD18–19). Inhibition of the ‘chemokine signalling pathway’ was com-
mon to both chondrocytes and tenocytes cultivated as a monolayer in comparison to those in three-dimensional 
culture systems. Alginate and fibrin cultures were shown to have significant activation of ‘osteoclast differen-
tiation’ and ‘HIF1 signalling’ pathways, respectively. These perturbed pathways were consistent with the gene 
ontology functional annotations.
Mechanistic networks for de- and redifferentiation transitions. To develop testable hypothetical 
mechanistic networks for de- and redifferentiation, upstream master regulators of the observed gene expression 
profiles for all pairwise comparisons, were inferred using Ingenuity® Pathway Analysis (IPA). The top scoring 
upstream regulators were ordered by ‘overlap p-value’, a measure of the enrichment of regulated genes within 
a data set, and by calculated ‘z-score’ for the predicted activation state of a regulator inferred from a test of the 
match in up- and down-regulation patterns. In all comparisons the top predictions for upstream regulators of the 
observed synthetic profile were TGF-β , TNF, and MYC. For the dedifferentiation transition in both chondrocytes, 
Fig. 5a,b, and tenocytes TGF-β mediated effects were predicted to be inhibited in native tissue, i.e. activated in 
dedifferentiation. Additionally, IL6 was predicted for chondrocytes and HIF1α and PDGF BB for tenocytes.
Further evidence of consensus for upstream regulators was evident in analysis of the expression data for the 
transition between two- and three-dimensional culture systems. For both alginate, Fig. 6a,b, and fibrin cultures 
the gene expression profiles were consistent with PDGF BB and TNF as activated upstream regulators. Reciprocal 
activation was predicted for the small molecule inhibitor of PI3K signalling, LY294004, and PI3K activator PDGF 
BB in 3D cultures, consistent with SPIA prediction of activation of the PI3K pathway in redifferentiation.
Source | Cartilage Selected genes Source | Tendon Selected genes
Cartilage
ECM - Col2a1, Acan, Thbs4, Alpl, Clu, 
Dmp1, Ibsp, Prg2, Prg3
Tendon
Myosins | Troponins - Tnnc2, 
Myl1, Mylpf, Tnni2
Cathepsins – Ctsk, Ctsg, Ctsc, Ctse, 
Ctss; ECM- Eln, Kera, Prg4, Dpt, Vcan
Wnt-signalling – Frzb Differentiated – Tnmd*, Serpinf1*, Mustn1*, Igfbp6, Thbs4, Myod1 
Chemokines – Il18, Ccl1, Ccl5 Transcription factors – Bmp1, Bmp7, Fos
Immune-associated – Tlr7, Defa5, 
Camp Homeobox – Hopx, Tbx15
CCN-family – Ccn2/Ctgf, Wisp1, 
Wisp2
Homeobox – Hopx, Satb1, Satb2, 
Hhex
Monolayer 
(chondrocytes)
Mesenchymal markers – CD90/
Thy1*, Prnp*, Snai1, Twist1
Monolayer 
(tenocytes) 
Mesenchymal markers – CD90/
Thy1*, Prnp*, Twist1
High-expression – Mmp3, Tgfb2, 
Thbs2, Col8a1
High-expression - Pla2g7, Hmox1, 
Itga11, Spp1, Serpine1
Wnt-signalling – Fzd1, Fzd2, Fzd8 Developmental – Irx5, Grem1, Runx1, Slit3*
Homeodomain – Pitx1*, Prrx2, Six1, 
Hoxa9, Hoxa10, Hoxc10, and Hoxd10 
Transcription factors – Cebpb, 
Cebpg
TGF-beta signalling – Tgfb2, Tgfb3, 
Smad6, Smad7 
Alginate cultures
Oxidative stress – Hif1a*, Atf4*, 
Nfe2l2*, Hmox1, Sod2
Fibrin cultures 
Developmental – Grem1, Tnn
Chemokines - Ccl2, Ccl2, Cxcl1, 
Cxcl13, Cxcl16 
Oxidative stress – Nfe2l2*, Hif1a*, 
Hmox1, Sod2
Cytokines - Il6, Tnfsf15, Tnfsf13 Osteogenic – Runx1, Gpnmb
Immune-mediators – Tlr2, Tlr3, 
S100a4, S100b Chemokines – Cxcl1, Ptgs2
Chondrogenesis – Scrg1, Id1, Bhlhb2/
Dec1
3D-associated – Clu, Vegfb, Fos, 
Junb, Atf3
Metalloproteinases – Mmp3, Mmp14, 
Adamts1
Metalloproteinases - Adamts1, 
Mmp11 
Table 2.  Differentially expressed genes selected for high expression in pairwise comparisons between 
native tissue and in vitro cultures. Threshold for differential expression was: log2 fold change > 0.5 (fold change 
> 1.4), adjusted p-value (false discovery rate, FDR) < 0.05, and B-statistic (log-odds ratio) > 0. Expression 
validation by qPCR is highlight by an asterisk (*). ECM- extracellular matrix. A complete list of differentially 
expressed genes passing filtering thresholds, for each pairwise comparison, are found in Supplementary Data, 
SD8–SD17.
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Discussion
The study sought to define testable mechanistic networks for de- and redifferentiation to establish the framework 
for iterative systems analysis, quantitative modelling, and to drive rational improvements in cell culture models 
for cartilage and tendon. This was based upon the hypothesis that comparable mechanisms regulated de- and 
re-differentiation in both cell types. The objectives of the study contributed to the wider goal of defining gene reg-
ulatory networks that may contribute to degenerative phenotypes in cartilage and tendon and, therefore, inform 
evidence-based development of organotypic culture systems in tissue engineering. Exploiting any inherent plas-
ticity in musculoskeletal cells for regenerative purposes may be possible through a deeper understanding of these 
mechanisms. Although dedifferentiation of chondrocytes in monolayer culture has been an observed phenom-
enon for over 30 years12 this is the first comprehensive profiling and systematic comparison of musculoskeletal 
cells and mechanistic interpretation of this phenotype with a view to establishing systems models for de- and 
re-differentiation as potential mechanisms in regenerative therapy for cartilage and tendon.
A striking finding of this study was the phenotypic drift of musculoskeletal cells in monolayer culture and 
convergence of the gene expression profiles for chondrocytes, tenocytes, and dermal fibroblasts at passage five. 
Fewer than three-hundred genes were found to be differentially expressed between dedifferentiated chondrocytes 
and tenocytes. Of the most highly differentially expressed, only twenty-five had a log2 fold-change greater than 
two. Despite monolayer culture representing a fundamental research tool and pre-requisite for autologous cell 
therapy18 there is little scrutiny or comparison of gene expression profiles across musculoskeletal cell types. Given 
the reduction in the complexity of the monolayer environment from tissue this finding is perhaps not surprising. 
Although this phenomenon has not been described before for cartilage and tendon cells expression profile con-
vergence in monolayer has been reported elsewhere19,20.
Dedifferentiation was confirmed by reductions in the expression of hallmarks of functionality in cartilage 
(Col2a1, Agcn) and tendon (Tnmd, Serpinf1). Loss of this functional synthetic profile was characterised by ele-
vated expression of genes commonly associated with markers of mesenchymal stem cell status (Thy1, Prnp)21–24 
and musculoskeletal developmental processes (Pitx1, Scx, Slit3). The homeobox gene Pitx125, associated with 
specification of the hind limbs, was significantly upregulated in dedifferentiated chondrocytes; Slit3, homolog of 
slit (Drosophila), known to have a tendon-associated knock-out phenotype in mice26, was up-regulated in ten-
ocytes in culture. In Drosophila, slit, secreted by tendon progenitors influences myotube migration through the 
ROBO receptor27 making this a potentially interesting marker of nascent tendon-like structures in vitro.
Figure 2. Box-and-whisker plots showing the distribution of normalised and transformed cycle threshold 
qPCR values (y-axis, 2^-dCt) for three experimental conditions (x-axis, cartilage | monolayer | alginate) 
for selected genes (right side vertical legend). Box and whisker plots show mean, first and third quartiles, and 
maximum and minimum values. Results shown are for technical triplicates on n = 4 (cartilage, monolayer) or 
n = 3 (alginate) biological replicates. Results of hypothesis testing (p-values) for differences between groups, 
after post-hoc corrections, are shown where thresholds are met.
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Cartilage and tendon progenitors in the limb have been defined principally by the binary expression of Sox9 or 
Scx respectively; mesenchymal progenitor cells, although having a close temperospatial relationship diverge into 
cells with restricted lineage28. Contemporary studies suggest that cell-fate determination based upon the categor-
ical expression of Sox9 or Scx is insufficient; evidence supports the presence of Sox9+/Scx+ sub-populations of 
tendon and cartilage progenitors that enable the formation of transitional zones between nascent musculoskeletal 
tissues2. Consequently, temporally co-ordinated signals from numerous effector pathways define the divergent 
cell fates1. Dedifferentiated chondrocytes and tenocytes both exhibited higher expression of Scx relative to native 
tissue by qPCR. For tenocytes, Scx expression remained high in fibrin cultures. Expression of Sox9, diminished in 
monolayer chondrocytes and tenocytes, was significantly elevated in alginate cultures. Overall, this demonstrated 
the higher expression of developmental modulators of tendon (Scx) and cartilage (Sox9) in 3D culture, but an 
overall failure to restitute the differentiated synthetic profile. Notably, direct conversion to a chondrocytic pheno-
type is possible when monolayer tenocytes are exposed to Sox929, indicating the transdifferentiation potential for 
cultured musculoskeletal cells.
In general, the proliferative phenotype of musculoskeletal cells in monolayer culture exhibits some of the syn-
thetic profile of predifferentiated mesenchymal cells. Consequently, a working qualitative definition of dediffer-
entiated musculoskeletal cells should make reference to ‘a proliferative, pre-differentiated phenotype expressing 
a number of key markers of musculoskeletal progenitors’ with the caveat that with the currently available data 
equivalence with musculoskeletal progenitors cannot be made. Global gene expression comparisons between 
monolayer-expanded cells, putative adult tissue-resident somatic ‘stem cells’, and mesenchymal stem cells would 
rationalise this definition and clarify ambiguities associated with these cell types in differentiation studies.
Improvements to organo-typic models for cartilage and tendon have been ad hoc and do not represent the 
iterative analysis of synthetic profiles relative to native tissue. Studies often assert improvements through a lim-
ited number of differentiation markers without consideration for the gene regulatory networks that underlie the 
phenotypic changes. Previous studies have demonstrated the redifferentiation potential of three-dimensional 
constructs for both dedifferentiated chondrocytes12,30 and tenocytes31, but have not addressed parity with native 
tissue at a global gene expression level.
Although three-dimensional culture models failed to restitute the native gene expression profile instead they 
provide novel insights into musculoskeletal cell responses to novel environments. Common to both models was 
evidence of differential expression of genes associated with inflammation, differentiation, and oxidative stress. 
Alginate beads demonstrated both a pro-inflammatory and differentiation-associated synthetic profile with the 
Figure 3. Box-and-whisker plots showing the distribution of normalised and transformed cycle threshold 
qPCR values (y-axis, 2^-dCt) for three experimental conditions (x-axis, tendon | monolayer | fibrin 
cultures) for selected genes (vertical legends). Box and whisker plots show mean, first and third quartiles, 
and maximum and minimum values. Results for technical triplicates on n = 4 biological replicates. Results 
of hypothesis testing (p-values) for differences between groups, after post-hoc corrections, are shown where 
thresholds are met; NSD – no significant difference.
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putative osteoarthritis biomarker Chi3l132 the most highly expressed. Similarly, in fibrin cultures markers of dif-
ferentiation were not restored; Cxcl1 and Cox2 were found alongside expression of development genes including 
Mfap5 (associated with E14.5 tendon development)33, Scx, and Grem1 (Gremlin1)34.
Both three-dimensional constructs were associated with evidence of oxidative stress and hypoxia shown 
by the significant upregulation of Atf4, Nfe2l2 (also known as Nrf2), and Hif1a by qPCR and microarray, gene 
ontology annotations, and Signalling Pathway Impact Analysis. Using Ingenuity® Pathway Analysis mechanis-
tic networks inferred an ‘NFE2L2-mediated oxidative stress response’. In physiological states NFE2L2 is consti-
tuitively expressed, but in conditions of oxidative stress rapid degradation by ubiquitination does not occur35. 
Consequently, NFE2L2 translocates to the nucleus, where it binds as a heterodimer with MAF proteins, or ATF4, 
to antioxidant responsive elements (ARE) in upstream regulatory regions of phase II antioxidant genes (Hmox1) 
to initiate their transcription.
Oxidative stress is considered a critical route to the development of dysfunctional cartilage and tendon includ-
ing in osteoarthritis and tendinopathy (rotator cuff36, fluroquinonlone-induced tendon rupture37). NFE2L2 sig-
nalling and antioxidant transcripts are relevant to the protection of cartilage. Cartilage erosion is exacerbated in 
induced arthritis in NFE2L2 knock-out mice relative to wild-type38. Inhibition of histone deactylase, facilitat-
ing NFE2L2 activation, also protected against cartilage destruction in Nfe2l2-KO mice in two models of OA39. 
NFE2L2 is also reported as a negative regulator of chondrogenesis in vitro, with expression limited to prolifer-
ative and pre-hypertrophic groups in embryonic mouse tibia40 as such, demonstrating a differentiation role for 
NFE2L2 in chondrocytes. It is not clear whether the upregulation of Nfe2l2, in response to oxidative stress in 
alginate cultures, had a negative effect on chondrogenic differentiation.
In summary, the three-dimensional culture models represent elements of oxidative stress, expression of chon-
drogenic and tenogenic markers, expression of inflammatory chemokines and a lack of expression of functional 
differentiation markers. These culture models may be more representative, in qualitative terms, of a dysregulated 
musculoskeletal cell phenotype rather than a suitable in vitro proxy for cartilage or tendon.
A plethora of signalling pathways have been implicated in de- and redifferentiation transitions including 
TGF-beta/SMAD, PI3K/AKT, Wnt-/beta-catenin, Notch, MAPK, and ERK14. Similarly, the same pathways are 
defined as being relevant to musculoskeletal disease41 and limb42, cartilage43 and tendon33 development. Further, 
Figure 4. Schematic representation of gene expression profile comparisons made between each 
experimental condition and cell type. Each comparison (legend) is annotated with the most significant KEGG 
reference pathways and the activation status of that pathway as predicted using a Signalling Pathway Topology 
Analysis (SPIA), Supplementary Data, SD18,19. For each comparison and cell type the trend in expression of 
genes validated by qPCR is indicated, for example, in dedifferentiation a reduction in the expression of Col2a1 
and Acan is found in chondrocytes. Common upstream master regulators predicted to be associated with the 
observed gene expression profiles, from Ingenuity® Pathway Analysis, are also provided.
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Figure 5. (a) Hypothetical mechanistic network derived from differentially expressed gene expression profile 
for cartilage versus dedifferentiated chondrocytes (dedifferentiation transition). Network consists of genes 
(nodes) connected by lines (edges) indicating a known relationship/interaction in the IPA® Knowledge Base. 
Genes more highly expressed in cartilage are coloured red; genes showing low expression in cartilage (i.e. 
higher in monolayer) are coloured green. Figure prediction legend describes the nature of edges joining nodes. 
Upstream regulators, and intermediate nodes (Jun, Smad3, Il6, Tnf), were predicted to be activated (orange) or 
inhibited (blue) consistent with the gene expression profile supplied; the direction and nature of the relationship 
is also indicated. Based upon the observed gene expression profile Tgf-β1 was predicted to be a key upstream 
regulator (z-score -2.65, overlap p-value 5.41e-26) of 740 differentially expressed genes; the actions of Tgf-β1 
were predicted to be inhibited in native cartilage where expression of Smad7, Bgn, and Ctgf were low relative to 
monolayer chondrocytes at passage five. Functional annotations for ‘differentiation of chondrocytes’ (3.66e-11), 
and ‘differentiation of connective tissue cells’ (5.6e-21, inhibited) were significantly enriched for this subnetwork 
and indicated a differentiation process; (b) Using the same elements a protein-protein association network 
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the genetic susceptibility to OA is known to be associated with a number of biological pathways44. Despite 
this, the core regulatory mechanisms, integration/cross-talk, and the temporal nature of these signals have not 
been defined. Consequently, a deeper understanding of the molecular mechanisms governing phenotypic plas-
ticity of cartilage and tendon cells for in vitro models should assist with an understanding of musculoskeletal 
pathophysiology.
In this study known master regulators are predicted to be associated with the observed phenotypes includ-
ing TGF-β (monolayer cultures) and PDGF BB (three-dimensional cultures). Using a Signalling Pathway 
Impact Analysis approach to understand signalling pathway perturbations this study demonstrates PI3K- and 
HIF1-signalling to be associated with both de- and redifferentiation; both native tendon and cartilage show acti-
vation of reference pathways for rheumatoid arthritis and systemic lupus erythematosus, whilst 3D cultures were 
both activated for chemokine signalling.
Although the same signalling pathways regulating in vitro phenotypes are associated with cartilage and 
tendon disease, there is insufficient evidence to assume that the same gene regulatory mechanisms are in play. 
Additionally, it is not clear whether de- and redifferentiation operate as a bidirectional process or which elements 
predominate during these transitions, although comparable intermediate regulators are predicted within mech-
anistic networks for both.
The study develops hypothetical mechanistic models using the predicted regulators of the observed gene 
expression profiles in all comparisons. These represent testable networks for future quantitative modelling to 
establish approaches to sustain or direct differentiation. These in silico models can be then iteratively tested in the 
established in vitro 3D models using the reference data provided here. Despite evidence that the upstream regula-
tion of de- and re-differentiation is likely to be the same in both tissues there were many differences in predicted 
pathways between the two, most likely due to the clear difference in the complexity of the synthetic profiles arising 
from matrix components. Experimental approaches that reduce the complexity of the system may help establish 
more robust models.
Although numerous tools exist for the development of complex three-dimensional in vitro models in muscu-
loskeletal biology the underlying gene regulatory mechanisms are still not understood well enough to inform the 
design process. Multiple obstacles to development of in vitro models exist, not least of which is gene and protein 
expression data of sufficient depth4. Developing robust in vitro models is essential for safety and efficacy studies, 
but also to sufficiently inform human disease. This study demonstrates that for both cartilage and tendon cells 
current in vitro standards fall short of what is required. Future experimental systems must be designed in concert 
with mathematical models to integrate the complex biomechanical and biochemical signalling45.
Materials and Methods
Materials. Reagents were purchased from Sigma or Life Technologies except where indicated.
Cell culture. Tail, common calcanean (Achilles), and hind limb deep digital flexor tendons, cartilage from 
the coxo-femoral and femorotibial joints, and dermis from the left flank were dissected from 3 month old male 
F344 rats (248 ± 25.5 g) (Charles River or Harlan Laboratories), after termination in accordance with Schedule 1 
of the UK Animals (Scientific Procedures) Act 1986. Animal usage for this study was approved by the University 
of Liverpool Animal Welfare Committee. Cells were isolated by collagenase digestion (0.2%, type 2, Worthington) 
for 12–18 hours at 37 °C. Tendon and dermal tissue also underwent an initial 1 hour incubation in 0.25% trypsin. 
Cells were seeded, subsequently split 1:2 and passaged five times in Dulbecco’s Modified Eagle’s Medium (DMEM) 
with GlutaMAX, supplemented with penicillin (100 U/mL), streptomycin (100 μ g/mL), amphotericin B (2 μ g/mL), 
and foetal calf serum (10%) at 37 °C and in 5% CO2. Chondrocytes were then seeded into alginate (1.2%) at a 
density of 2 × 106 cells/mL as per46 and grown in supplemented DMEM containing L-ascorbic acid-2-phosphate 
(200 μ M) for two weeks. Tenocytes (7.5 × 105 cells per construct) were seeded into fibrin gels as described47 and 
grown in supplemented DMEM containing L-ascorbic acid-2-phosphate (200 μ M) and aprotinin (20 μ g/ml) for 
7–10 days until fully contracted.
RNA isolation and microarray. Tissues and three-dimensional (3D) tendon fibrin constructs were stored 
directly in RNAlater (Ambion, Life Technologies) according to the manufacturer’s instructions and pulver-
ised under N2(l). Alginate beads were incubated with sodium citrate (55 mM), sodium chloride (150 mM), pH 
6 for 10 minutes at 37 °C with shaking. The cell pellet was recovered by centrifugation and washed twice in PBS. 
Ground tissue, cell pellets and monolayer cells were incubated at room temperature in TRIzol Reagent for 10 min-
utes. RNA was extracted using a single-step method48. Following RNA resuspension in 75% ethanol, DNAse 
digestion and purification were performed using RNeasy spin columns (Qiagen). RNA was quantified using an 
ND1000 spectrophotometer (ThermoScientific) and submitted to The Genome Centre, Barts and the London 
Medical School, UK. RNA integrity was measured using a Bioanalyser (Agilent) and samples analysed using the 
RatRef-12 v1 Expression BeadChip array (Illumina).
consisting of nodes (proteins) and edges (evidence of associations) indicates a shared function between selected 
nodes, but not necessarily physical interactions. Sources for evidence of associations are defined in the network 
legend. Elements determined to influence differentiation status of chondrocytes and tenocytes in culture using 
IPA® are shown to have significant enrichment for protein-protein interactions (p < 0.0001) indicating that as a 
group they are biologically connected.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:33956 | DOI: 10.1038/srep33956
Figure 6. (a) Hypothetical mechanistic network derived from predicted upstream regulators for genes 
found to be differentially expression in chondrocytes in transition from monolayer to alginate bead cultures 
(redifferentiation). Genes showing lower expression in monolayer relative to alginate beads (Hif1a, Nfe2l2, 
Atf3) are coloured green (i.e. indicating higher expression in alginate cultures); genes in orange are predicted. 
Genes more highly expressed in monolayer are not shown (absence of red-coloured genes). In monolayer 
chondrocytes PDGF BB mediated effects are predicted to be inactive for the observed expression profile, i.e. 
activated in alginate cultures. Ingenuity® canonical pathways significantly enriched for this expression profile 
included ‘NRF2-mediated oxidative stress’, ‘PI3K/AKT signalling’ and ‘the role of osteoblasts, osteoclasts and 
chondrocytes in rheumatoid arthritis’. The physiological function terms ‘differentiation of cells’ (p = 1.6e-14) 
and ‘apoptosis’ (p = 4.9e-12) were highly enriched in this subnetwork. Nodes with a pink border were enriched 
for ‘condensation of cartilage tissue’, p = 2.07e-7. The small molecule inhibitor of the PI3K/AKT pathway 
‘LY294004’ was predicted to be activated based upon the supplied gene expression profile (z-score = 4.58, 
overlap p-value = 3.3e-15, 219 gene interactions). This mechanistic network indicates that PI3K signalling 
and PDGF BB are likely to be active in the redifferentiation phenotype in alginate cultures; the PI3K inhibitor 
LY294004 describes the inverse for monolayer cells. (b) Using the same elements a protein-protein association 
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Gene expression and pathway analysis. Analysis of raw expression data from 36 arrays was performed 
using R (version 3.0.2) and the Bioconductor packages beadarray (v2.6.0)49 and limma. Data was pre-processed, 
loess-normalized and log2-transformed. The number of biological replicates for each condition was; native 
cartilage, 4; native tendon, 5; passaged chondrocytes, 8; passaged tenocytes, 8; passaged dermal fibroblasts, 3; 
chondrocytes in 3D alginate culture, 4; and tenocytes or chondrocytes in 3D fibrin constructs, 4. For pairwise 
comparisons log2 fold change > 0.5 (fold change > 1.4), ‘adjusted p-value’ (false discovery rate, FDR) < 0.05 and 
B-statistic (log-odds ratio) > 0 cut-offs were used.
Unsupervised hierarchical clustering and principal component analysis (PCA) was carried out for the most 
covariant genes (> 0.8) using the WGCNA methodology50. Gene Ontology (GO) analysis was performed using 
the Database for Annotation, Visualization and Integrated Discovery (DAVID, https://david.ncifcrf.gov)51 and 
hypergeometric analysis using GOstats52. Output GO lists were rationalised using ReviGO (http://revigo.irb.hr)53. 
The ‘SimRel’ algorithm was used to calculate the semantic similarity score; allowed similarity was set to ‘Medium 
(0.7)’. The UniProt Rattus norvegicus database (2013) was used to define the search space. Only terms with a FDR 
< 0.001 were used.
Signalling Pathway Impact Analysis (SPIA)54 was applied to 58 KEGG55 (The Kyoto Encyclopedia of Genes 
and Genomes, http://www.genome.jp/kegg/) Rattus norvegicus canonical signalling pathways in XML format. 
Differential expression lists consisting of Entrez gene identifiers and log2 fold-changes were used as the input 
to the SPIA pathway topology package in R, with an FDR-adjusted p-value < 0.05 considered significant. SPIA 
uses an impact analysis technique, which makes use of both the over-representation of differentially expressed 
genes in a given pathway and the pathway topology, or structure, to infer perturbations to KEGG canonical sig-
nalling pathways and predict an activation state based upon the measured expression change (log2 fold-change). 
A boot-strapping process was used to define the total pathway perturbation and define a global probability value 
that a pathway was significantly perturbed (after FDR adjustment) in a given comparison. Both positive and neg-
ative log2-fold-changes from each experimental comparison was used as an input to SPIA to provide an adequate 
description for de- and re-differentiation transitions for each tissue.
To infer upstream master regulators of the observed gene expression profile and generate hypothesis net-
works the Ingenuity® Pathway Analysis (IPA®, Qiagen Bioinformatics, Redwood City, USA, www.ingenuity.com) 
knowledge base and software implementing causal analysis methods56 were used under license. Briefly, regulators 
with network connections to, and the direction of regulation within, the expression dataset were scored on their 
likelihood of occurring more frequently than in a random model. The top upstream regulators (including: tran-
scription factors, small molecules, endogenous chemicals, miRNAs) were defined in this study as those with: i) 
the smallest ‘overlap p-value’ – a measure of enrichment of regulated genes within a dataset using a Fisher’s Exact 
Test (right-tailed), and ii) the highest ‘activation z-score’ – the activation state of a regulator inferred from a test 
of the match in up- and down-regulation patterns. To build on the mechanistic networks predicted through IPA, 
downstream targets of transcription factors were collected from the existing gene expression dataset. Only those 
genes that were differentially expressed and had a direct relationship with the master regulators were chosen. To 
mitigate bias in the selection and addition of nodes (genes) or functional annotations to the network only those 
arising from earlier analysis (qPCR, SPIA, GO analysis) were included. Protein-protein association networks were 
defined using STRING (www.string-db.org)57 for Rattus norvegicus using medium confidence settings.
Quantitative RT-PCR. Reverse transcription was carried out using M-MLV reverse transcriptase and 
random-hexamer oligonucleotides (Promega). Quantitative PCR was carried out using Takyon MasterMix Plus, 
ROX for SYBR Assay (Eurogentec) on a AB7300 instrument (Applied Biosystems). Amplicons were verified by 
melt-curve analysis and gel electrophoresis. All primers (Supplementary Data, SD20) had efficiencies over 90%. 
Gene expression levels were normalised to Rps20, shown to have the most stable expression across all sample types 
using the geNorm algorithm58, using the comparative Ct method59 on using 3–4 four biological replicates, inde-
pendent of samples used for microarray gene expression profiles, with all qPCR reactions performed in triplicate. 
Normalised Ct data were converted to the linear form (2−ΔCt) for statistical analysis. Following Shapiro-Wilks and 
Levene’s tests, differences between conditions were analysed by one-way ANOVA with Games-Howell post-hoc 
test for unequal variance between groups.
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